Dictyostelium discoideum as a non-mammalian biomedical model.
Javier Martín-GonzálezJavier-Fernando Montero-BullónJesus LacalPublished in: Microbial biotechnology (2020)
Dictyostelium discoideum is one of eight non-mammalian model organisms recognized by the National Institute of Health for the study of human pathology. The use of this slime mould is possible owing to similarities in cell structure, behaviour and intracellular signalling with mammalian cells. Its haploid set of chromosomes completely sequenced amenable to genetic manipulation, its unique and short life cycle with unicellular and multicellular stages, and phenotypic richness encoding many human orthologues, make Dictyostelium a representative and simple model organism to unveil cellular processes in human disease. Dictyostelium studies within the biomedical field have provided fundamental knowledge in the areas of bacterial infection, immune cell chemotaxis, autophagy/phagocytosis and mitochondrial and neurological disorders. Consequently, Dictyostelium has been used to the development of related pharmacological treatments. Herein, we review the utilization of Dictyostelium as a model organism in biomedicine.
Keyphrases
- endothelial cells
- healthcare
- induced pluripotent stem cells
- oxidative stress
- pluripotent stem cells
- public health
- stem cells
- gene expression
- mesenchymal stem cells
- single cell
- dna methylation
- quality improvement
- cross sectional
- blood brain barrier
- endoplasmic reticulum stress
- risk assessment
- climate change
- social media